Tag: breast cancer

pCR in HER2+ Breast Cancer Predicts Long-Term Survival

A pathologic complete response (pCR) to targeted therapy in HER2-positive breast cancer portends good long-term outcomes, according to final results of the phase 3 NeoALTTO/BIG...

Image-Guided Biopsy May Help Some Avoid Breast Cancer Surgery

NEW YORK (Reuters Health) – Following neoadjuvant chemotherapy, image-guided vacuum-assisted biopsy (VAB) can reliably identify a subgroup of patients with no residual disease in the...

Study Finding Patients of Female Surgeons Fare Better is Removed

An Elsevier journal has, for the moment, removed a paper which found that the patients of female surgeons fare better than those treated by men....

Textured Implants Linked to Increased Breast Cancer Recurrence Risk

NEW YORK (Reuters Health) – Using textured implants for reconstruction after mastectomy is associated with greater risk of breast cancer recurrence compared to smooth implants,...

Cell Therapy for Anthracycline Cardiomyopathy Safe, Feasible

In yet another trial of cell therapy for heart failure, this time in cancer survivors with anthracycline-induced cardiomyopathy (AIC), administration of allogeneic bone marrow-derived mesenchymal...

IISc team uses nanomotors to probe cancer cells | India News

BENGALURU: The Indian Institute of Science (IISc) on Wednesday said that an interdisciplinary team of researchers from the institute has used a 3D tumour model...

Survey Quantifies COVID-19’s Impact on Oncology

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. An international survey provides new insights into how COVID-19 has affected,...

Threefold Higher Risk for Breast Cancer Death With DCIS

For women diagnosed with ductal carcinoma in situ (DCIS), the risk of dying of breast cancer was three times higher than among women in the...

Medicare Will Test Pay Models for Radiation Oncology, Dialysis

Beginning in 2021, Medicare will test alternative methods of paying for radiation oncology and dialysis, with the giant federal insurer saying it is seeking to...

Hair Dye and Cancer Study ‘Offers Some Reassurance’

The largest study of its kind has found no positive association between personal use of permanent hair dye and the risk for most cancers and...

Gene Signature May Improve Prognostication in Ovarian Cancer

A new gene expression signature could improve on conventional risk factors when it comes to estimating prognosis and selecting treatment in patients with high-grade serous...

Oncologists Train ARDS Docs for ‘Inspirational’ COVID-19 Trial

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Oncologists in the long-running I-SPY 2 platform trial are training physicians...

Chronicles of Cancer: A History of Mammography

The history of mammography provides a powerful example of the connection between social factors and the rise of a medical technology. It is also an...

Treat Obesity Like Breast Cancer, With Empathy, Say Canadians

A new Canadian clinical practice guideline for treating adults with obesity emphasizes improving health rather than simply losing weight, among other things. A summary of...

Higher Death Rate in Cancer Patients With Nosocomial COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Hospitalized cancer patients have a high risk of nosocomial COVID-19 that...

Support for Chemo in Some Older Women With Breast Cancer, Comorbid Conditions

NEW YORK (Reuters Health) – Adjuvant chemotherapy can improve overall survival in elderly women with node-positive, estrogen receptor-positive breast cancer and multiple comorbidities, according a...

Does Obesity Reduce Drug Efficacy in Breast Cancer?

Obesity has been shown to have an impact on the risk of developing breast cancer and on prognosis. A new study suggests that it may...

Take 10 With Betsey Johnson

Betsey Johnson Fashion designer, 77, Malibu, CA Last year, after having three seizures, you had...

FDA Approves Olaparib for Certain Metastatic Prostate Cancers

The US Food and Drug Administration approved olaparib (Lynparza, AstraZeneca) for deleterious or suspected deleterious germline or somatic homologous recombination repair (HRR) gene-mutated metastatic castration-resistant...

HRT Update Regarding Breast Cancer Risk Advised in EU

In concluding their review of hormone replacement therapy (HRT) and the associated risk of breast cancer, the EU Pharmacovigilance Risk Assessment Committee (PRAC) has recommended...

First PARP Inhibitor Approved for Metastatic Prostate Cancer

A completely new approach to the treatment of prostate cancer is now available to clinicians through the approval of the first PARP inhibitor for use...

Adding a Blood Test to Screening May Improve Cancer Detection

A minimally invasive multicancer blood test used with standard-of-care screening is safe, effective, and feasible for use in routine clinical care, according to interim findings...

Will Coronavirus Restrictions Lead to More Advanced Cancers?

What your doctor is reading on Medscape.com: APRIL 22, 2020 — My pathology lab once faced a daily flood of colon polyps, pap smears,...

Cognitive Decline With Endocrine Tx for Breast Ca

Cognitive impairment seen in women with early breast cancer who undergo chemotherapy ― so-called chemobrain ― has now been reported in patients who are treated...

‘Encouraging’ Results With Pre-Op Therapy for DCIS

First-of-its-kind findings suggest that hormonal therapy could be the primary treatment instead of surgery for women who are diagnosed with a precursor of breast cancer,...